TARGET Candidate Submission Form
The goal of this form is to nominate new genes that, when altered in cancer, are linked to clinical actions. These actions include predicting response or resistance to targeted therapies, and/or having prognostic or diagnostic utility.

Each gene requires a separate entry and new entries are reviewed quarterly. If your entry is selected for inclusion, you will be notified and acknowledged as the entry expert if you approve.

If you have specific questions related to TARGET, please contact us at:

phial-help@broadinstitute.org

For information regarding the TARGET gene set, please see:

Van Allen EM, Wagle N, et al. In Review 2013.

____________________________________________________

Contact Information
What is your name? *
Last, First (e.g. Rous, Peyton)
Your answer
What is your email? *
Your answer
What is your current occupation or title?
What institution are you affiliated with?
Your answer
TARGET Nomination
What is the HUGO Symbol? *
All gene names must be given by their HUGO Symbol (http://www.genenames.org/).
Your answer
What types of alterations in this gene are associated with the particular clinical action?
You may select one or more alteration category types that link genes to clinical actions.
What clinical actions are associated with this gene/alteration combination? *
Please provide clinical actions as specifically as possible and include citations as either PubMed IDs, Abstract IDs, or URLS in parentheses (e.g. "1. BRAF V600E somatic alterations are associated with response to RAF inhibitors in metastatic melanoma (PMID: 21639808, 22356324).") Please number clinical actions and include only one per line.
Your answer
Please provide any additional comments about this nomination you could not include in other fields
Your answer
Would you like to be acknowledged as the expert for this entry if it is included in TARGET? *
Submit
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service